Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study

NCT ID: NCT03222011

Last Updated: 2020-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-09

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Two thirds of patients with Crohn's disease require intestinal surgery at some time in their life. Intestinal strictures, that is narrowing of the bowel due to inflammation and scarring, are the most common reason for surgery. Despite the high frequency, associated disability, and cost there are no are no treatment strategies that aim to improve the outcome of this disease complication. The STRIDENT (stricture definition and treatment) studies aim to develop such strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective randomised controlled study. Patients with Crohn's Disease and symptomatic stricture(s) will undergo randomisation to receive standard or intensive endoscopic therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn Disease Inflammatory Bowel Diseases Stricture; Bowel

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomised controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Open label study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard endoscopic therapy

Single endoscopic dilatation

Group Type ACTIVE_COMPARATOR

Standard (single) endoscopic stricture dilatation

Intervention Type PROCEDURE

single endoscopic stricture dilatation

Intensive endoscopic therapy

3 endoscopic dilatations 3 weeks apart and possible needle knife strictureplasty

Group Type EXPERIMENTAL

Intensive endoscopic stricture dilatation

Intervention Type PROCEDURE

3 endoscopic dilatations 3 weeks apart and possible needle knife strictureplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard (single) endoscopic stricture dilatation

single endoscopic stricture dilatation

Intervention Type PROCEDURE

Intensive endoscopic stricture dilatation

3 endoscopic dilatations 3 weeks apart and possible needle knife strictureplasty

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Inflammatory bowel disease patients with intestinal stricture(s) identified on CT, MRI or endoscopy.

Exclusion Criteria

* Acute bowel obstruction requiring urgent surgical intervention
* Deemed by treating physician to have high risk of acute bowel obstruction
* Concurrent active perianal sepsis
* Internal fistulising disease in association with strictures (entero-enteric stulas)
* Low rectal or anal strictures
* Evidence of dysplasia or malignancy from stricture biopsies or adjacent mucosal biopsies
* Patients for whom endoscopy is not suitable due to co-morbidities or clinical state
* Inability to give informed consent
* Suspected perforation of the gastrointestinal tract
* Pregnancy
* Inability to undergo MRI small bowel due to a contraindication.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Australasian Gastro Intestinal Research Foundation

OTHER

Sponsor Role collaborator

St Vincent's Hospital Melbourne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Kamm

Professor of Gastroenterology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emily Wright, MBBS PhD

Role: PRINCIPAL_INVESTIGATOR

St Vincent's Hospital Melbourne

Bronte Holt, MBBS PhD

Role: PRINCIPAL_INVESTIGATOR

St Vincent's Hospital Melbourne

Michael Kamm, MBBS PhD

Role: PRINCIPAL_INVESTIGATOR

St Vincent's Hospital Melbourne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Vincent's Hospital Melbourne

Melbourne, Victoria, Australia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Australia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Julien Schulberg, MBBS

Role: CONTACT

+61 3 92312211

Amy Hamilton, PhD

Role: CONTACT

+61 3 92312211

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Julien Schulberg, MBBS

Role: primary

Amy Hamilton

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Schulberg JD, Hamilton AL, Wright EK, Holt BA, Sutherland TR, Ross AL, Vogrin S, Kamm MA. Repeated endoscopic dilation and needle-knife stricturotomy for Crohn's disease strictures. Gastrointest Endosc. 2025 Jan;101(1):202-206.e4. doi: 10.1016/j.gie.2024.09.031. Epub 2024 Sep 27.

Reference Type DERIVED
PMID: 39343051 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

StVincentsMelbourneSTRIDENT2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Response Assessment in SB CD
NCT03646708 RECRUITING
Microbial Restoration in Inflammatory Bowel Diseases
NCT04970446 RECRUITING PHASE1/PHASE2
The MOTOR-CD Trial
NCT05363930 COMPLETED NA